“Walk30x5”: A feasibility study of a physiotherapy walking programme for people with mild to moderate musculoskeletal conditions

Minns Lowe, Catherine J., Kelly, Paul, Milton, Karen, Foster, Charlie and Barker, Karen (2020) “Walk30x5”: A feasibility study of a physiotherapy walking programme for people with mild to moderate musculoskeletal conditions. Physiotherapy, 107. pp. 275-285. ISSN 0031-9406

[thumbnail of Accepted_Manuscript]
PDF (Accepted_Manuscript) - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (3MB) | Preview


Objectives: To explore the feasibility of delivering and evaluating a web-based walking intervention for people with long term musculoskeletal conditions (LTMCs), to determine its acceptability and the feasibility of conducting a definitive trial.  Design: Prospective randomised feasibility study, with blind outcome assessment at baseline, 3 and 6 months. Setting: Hospital based physiotherapy service. Participants: Forty one adults referred for assessment and advice for any mild/moderate LTMCs. doing <120 minutes of moderate intensity activity per week.  Interventions: Participants randomised to: 1. Usual care: one usual physiotherapy advice and assessment session, including setting a physical activity goal and one follow up session (8 weeks). 2. “Walk30 × 5”: session one, usual care plus intervention of walking programme. Participants were shown the website and podcasts and practiced how to use them. One follow up session (8 weeks). Outcome measures: Primary: timed six minute walk test (T6MWT). Secondary: step count, self-reported pain, fatigue, mood, self-efficacy, happiness, objective blood pressure, peak expiratory flow rate, and self-report and accelerometer measured physical activity.  Results: Recruitment target achieved. No adverse events occurred. Adherence was high and the intervention acceptable. Loss to follow up n = 3 (7%) at 3 months, n = 8 (20%) at 6 months. T6MWT and step count proved suitable outcomes, unlike accelerometry. Estimated sample size for a definitive trial is 216.  Conclusions: “Walk30 × 5” is ready for evaluation in a future, appropriately powered (n = 216), phase III trial. If effective, the intervention will provide a cheap, highly accessible intervention to enable people with mild/moderate LTMCs to achieve UK physical activity guidelines.  Clinical Trial Registration Number: ISRCTN78581097.

Item Type: Article
Uncontrolled Keywords: feasibility study,musculoskeletal conditions,physical activity,walking programme,web-based intervention,physical therapy, sports therapy and rehabilitation ,/dk/atira/pure/subjectarea/asjc/3600/3612
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 27 Sep 2019 09:30
Last Modified: 22 Oct 2022 05:16
URI: https://ueaeprints.uea.ac.uk/id/eprint/72405
DOI: 10.1016/j.physio.2019.08.010

Actions (login required)

View Item View Item